Search Results - Atreya, Imke

Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis

by Besendorf, Laura, Müller, Tanja M., Geppert, Carol-Immanuel, Schneider, Ines, Mühl, Laura, Atreya, Imke, Vitali, Francesco, Atreya, Raja, Neurath, Markus F., Zundler, Sebastian

Read online (freely available)

Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo

by Fischer, Anika, Zundler, Sebastian, Atreya, Raja, Rath, Timo, Voskens, Caroline, Hirschmann, Simon, López-Posadas, Rocío, Watson, Alastair, Becker, Christoph, Schuler, Gerold, Neufert, Clemens, Atreya, Imke, Neurath, Markus F.

Read online (freely available)

Anti-β7 integrin treatment impedes the recruitment on non‐classical monocytes to the gut and delays macrophage‐mediated intestinal wound healing

by Sommer, Katrin, Heidbreder, Karin, Kreiss, Lucas, Dedden, Mark, Paap, Eva‐Maria, Wiendl, Maximilian, Becker, Emily, Atreya, Raja, Müller, Tanja M., Atreya, Imke, Waldner, Maximilian, Schürmann, Sebastian, Friedrich, Oliver, Neurath, Markus F., Zundler, Sebastian

Read online (freely available)

Nr4a1-dependent non-classical monocytes are important for macrophage-mediated wound healing in the large intestine

by Heidbreder, Karin, Sommer, Katrin, Wiendl, Maximilian, Müller, Tanja M., Atreya, Imke, Hildner, Kai, Neurath, Markus F., Zundler, Sebastian

Read online (freely available)

Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets

by Becker, Emily, Schweda, Anna, Ullrich, Karen A. -M, Voskens, Caroline, Atreya, Raja, Müller, Tanja M., Atreya, Imke, Neurath, Markus F., Zundler, Sebastian

Read online (freely available)

Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study

by Mühl, Laura, Becker, Emily, Müller, Tanja M., Atreya, Raja, Atreya, Imke, Neurath, Markus F., Zundler, Sebastian

Read online (freely available)

Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study

by Allner, Clarissa, Melde, Michaela, Becker, Emily, Fuchs, Friederike, Mühl, Laura, Klenske, Entcho, Müller, Lisa, Morgenstern, Nadine, Fietkau, Konstantin, Hirschmann, Simon, Atreya, Raja, Atreya, Imke, Neurath, Markus F., Zundler, Sebastian

Read online (freely available)

Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease

by Lichnog, Charlotte, Klabunde, Sha, Becker, Emily, Fuh, Franklin, Tripal, Philipp, Atreya, Raja, Klenske, Entcho, Erickson, Rich, Chiu, Henry, Reed, Chae, Chung, Shan, Neufert, Clemens, Atreya, Imke, McBride, Jacqueline, Neurath, Markus F., Zundler, Sebastian

Read online (freely available)

Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles

by Fuchs, Friederike, Schillinger, Daniela, Atreya, Raja, Hirschmann, Simon, Fischer, Sarah, Neufert, Clemens, Atreya, Imke, Neurath, Markus F., Zundler, Sebastian

Read online (freely available)